ANGPT1 and COVID-19: While speculation, it seems reasonable that if the sex hormone modulator 17β-Oestradiol affects the expression and activity of the ACE2 receptor and increases Ang 1–7 levels; thus, hormone therapy offers a potential supportive treatment for female COVID-19 patients [30].